These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2827265)

  • 1. [Complement activation after the intravascular administration of contrast media: a comparison between ionic and nonionic x-ray contrast media].
    Hoffmeister HM; Fuhrer G; Platten HP; Heller W
    Rofo; 1987 Dec; 147(6):673-5. PubMed ID: 2827265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-ionic iodinated dimeric versus monomeric X-ray contrast media: effects on complement factors in vivo].
    Böhm I; Speck U; Schild H
    Rofo; 2006 Mar; 178(3):306-12. PubMed ID: 16508838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activation of the kallikrein-kinin system by intravenous administration of ionic and non-ionic radiographic contrast media].
    Hoffmeister HM; Fuhrer G; Abels GA; Pirschel J; Heller W
    Dtsch Med Wochenschr; 1988 Jul; 113(28-29):1138-41. PubMed ID: 3260554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 5. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
    Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
    Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the alternative pathway of the complement system by radiographic contrast media.
    Arroyave CM; Bhat KN; Crown R
    J Immunol; 1976 Nov; 117(5 Pt.2):1866-9. PubMed ID: 993582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of aging on complement activity (CH50) and complement protein levels.
    Nagaki K; Hiramatsu S; Inai S; Sasaki A
    J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation by iodinated contrast media.
    Hsieh KH; Chuang CM; Li SC; Lue HC; Lee TC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Jun; 13(2):115-20. PubMed ID: 7449528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of contrast media on renal function in children: comparison of ionic and non-ionic agents.
    Buyan N; Arab M; Hasanoğlu E; Gökçora N; Ercan S
    Turk J Pediatr; 1995; 37(4):305-13. PubMed ID: 8560597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in the kallikrein-kinin and complement system in angiography using non-ionic contrast media].
    Hoffmeister HM; Fuhrer G; Pirschel J; Heller W
    Klin Wochenschr; 1988 Sep; 66(17):760-3. PubMed ID: 3263537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood.
    Miyano A; Nakayama M; Fujita T; Kitajima H; Imai S; Shimizu A
    Diagn Clin Immunol; 1987; 5(2):86-90. PubMed ID: 3497734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of some complement components in azoospermic, oligospermic and normospermic Nigerian men.
    Oyeyinka GO; Bello CS; Elegba OY; Nsofor BI
    J Reprod Med; 1987 Oct; 32(10):774-6. PubMed ID: 3500310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The adverse effects of the water-soluble iodinated contrast media used in excretory urography in the canine species].
    Hita Rosino E; Agut Giménez A; Sánchez-Valverde García MA
    Actas Urol Esp; 1999 May; 23(5):385-93. PubMed ID: 10427811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of serum complement concentrations in tumour patients prior and after radiotherapy.
    Beyer-Enke SA; Strauss LG; Georgi M
    Strahlenther Onkol; 1986 Jul; 162(7):441-7. PubMed ID: 3488595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation by immunoglobulin does not depend solely on C1q binding.
    Bindon CI; Hale G; Waldmann H
    Eur J Immunol; 1990 Feb; 20(2):277-81. PubMed ID: 2311645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hereditary complement deficiencies].
    Fischer E
    Hautarzt; 1982 Feb; 33(2):65-72. PubMed ID: 6281215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in complement components after intravascular application of contrast media.
    Hoffmeister HM; Fuhrer G; Platten HP; Heller W
    Adv Exp Med Biol; 1989; 247B():585-9. PubMed ID: 2514582
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of hematocrit and iodine concentrations following intravenous bolus administration of ionic and nonionic monomeric and dimeric contrast media--an animal experimental study].
    Claussen CD; Duda SH; Weinmann HJ
    Rofo; 1988 Nov; 149(5):529-33. PubMed ID: 2848287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of immune precipitation by purified classical pathway complement components.
    Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
    Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.